GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Cencora Inc.
Cencora (formerly AmerisourceBergen) is one of the three pillars of the American drug distribution system. The company ensures the timely and safe delivery of pharmaceuticals from manufacturers to pharmacies and hospitals. It is a stable business with enormous scale.
Share prices of companies in the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the three largest wholesale pharmaceutical distributors in the United States. We classify it as part of the Pharmacy sector, and the chart below reflects the overall dynamics of this segment, which is a key link in the drug supply chain.
Broad Market Index - GURU.Markets
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. Its key role in the healthcare supply chain makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Cencora compares to it.
Change in the price of a company, segment, and market as a whole per day
COR - Daily change in the company's share price Cencora Inc.
For Cencora, a drug distributor, daily price changes reflect its stability and sensitivity to trends in the pharmaceutical industry. The graph of these fluctuations is unspectacular, but it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharmacy
Pharmaceutical distribution is a sector with relatively low volatility but high competition. This chart shows average daily fluctuations in the industry, in which Cencora is a leader. Comparing this to COR dynamics helps us understand how the company's scale makes it more stable than the industry.
Daily change in the price of a broad market stock, index - GURU.Markets
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. The healthcare sector is considered relatively defensive. The chart below shows general market fluctuations, which can be used to assess how Cencora is responding to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Cencora Inc.
Cencora (formerly AmerisourceBergen) is one of the three giants in drug distribution in the United States. Its business is the backbone of the entire healthcare system. Its year-over-year share price performance reflects its stability and key role in the pharmaceutical supply chain.
Annual dynamics of market capitalization of the market segment - Pharmacy
Cencora, Inc. (formerly AmerisourceBergen) is one of the three largest pharmaceutical distributors in the United States. The company is a critical link in the drug supply chain, ensuring a stable and predictable business. The chart shows how this infrastructural role affects its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors. Its business, like McKesson's, is characterized by low margins but stable and huge revenues. Its stock price reflects robust demand for medications, making the company a safe haven in the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Cencora Inc.
Cencora (formerly AmerisourceBergen), a giant drug distributor, demonstrates the stability of the healthcare system. The monthly fluctuations on the chart reflect the volume of medications supplied to pharmacies and hospitals, as well as pricing trends in the pharmaceutical market.
Monthly dynamics of market capitalization of the market segment - Pharmacy
This chart illustrates the dynamics of the drug distribution sector, where Cencora (formerly AmerisourceBergen) is one of three dominant players. Its steady growth reflects the continued demand for medications. It's a low-margin, yet huge and stable business.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cencora (formerly AmerisourceBergen) is one of the three largest pharmaceutical distributors in the US. It is a key link in the drug supply chain from manufacturer to pharmacy. The chart below shows general market fluctuations. How immune is Cencora's stable and critical business to these fluctuations?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Cencora Inc.
Cencora (formerly AmerisourceBergen) shares reflect the state of the US pharmaceutical supply chain. This drug distributor's weekly performance responds to prescription drug sales, manufacturer pricing policies, and regulatory changes in healthcare.
Weekly dynamics of market capitalization of the market segment - Pharmacy
Pharmaceutical distributors are the lifeblood of the healthcare system. The sector's weekly dynamics reflect drug sales volumes, pricing pressure, and regulatory changes affecting all major players. This chart illustrates this overall flow, which helps us understand Cencora's role.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cencora (formerly AmerisourceBergen) is a pharmaceutical distribution giant. Its business is characterized by stability and low margins, but huge revenues. The chart below will help determine whether Cencora shares are a safe haven, less susceptible to market storms due to its key role in healthcare.
Market capitalization of the company, segment and market as a whole
COR - Market capitalization of the company Cencora Inc.
Cencora's (formerly AmerisourceBergen) market capitalization chart reflects its central role in the US drug supply chain. Its growth reflects not the development of new drugs, but rather the giant logistics engine that connects pharmaceutical manufacturers and pharmacies. Its dynamics reflect the market's assessment of the company's indispensability to the healthcare system.
COR - Share of the company's market capitalization Cencora Inc. within the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of three giants dominating the wholesale drug distribution market in the US. Its colossal market share reflects its critical role in the drug supply chain from manufacturer to pharmacy. The chart shows the weight of this indispensable intermediary in the multi-trillion-dollar healthcare industry.
Market capitalization of the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the "big three" pharmaceutical distributors in the US. The chart below shows the total market capitalization of the healthcare sector. Its steady growth reflects the inelastic demand for drugs, and Cencora is a critical link in this vast supply chain.
Market capitalization of all companies included in a broad market index - GURU.Markets
Cencora (formerly AmerisourceBergen) is one of the invisible giants of healthcare, a wholesale distributor of drugs. Its enormous market capitalization reflects the scale of the pharmaceutical market. Looking at its share, you can see the enormous cash flow that flows through the supply chains that deliver drugs to pharmacies.
Book value capitalization of the company, segment and market as a whole
COR - Book value capitalization of the company Cencora Inc.
Cencora's material foundation is its gigantic automated warehouses and a complex logistics network for distributing pharmaceutical products. Its book value reflects the tangible assets that ensure timely delivery of medications to pharmacies and hospitals. How has this vital foundation grown? The chart below shows its growth dynamics.
COR - Share of the company's book capitalization Cencora Inc. within the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is a key player in drug supply, operating a massive network of warehouses and distribution centers. The chart shows the share of these logistics assets in the pharmaceutical sector, reflecting the scale of its physical infrastructure.
Market segment balance sheet capitalization - Pharmacy
Pharmaceutical distribution on Cencora's scale is a capital-intensive logistics operation. Compared to the assets of the entire sector, its business requires ownership of a gigantic network of automated warehouses and a fleet of vehicles. This makes it a "heavy" player, ensuring the movement of medications across the country.
Book value of all companies included in the broad market index - GURU.Markets
Cencora's (formerly AmerisourceBergen) assets are not production lines, but one of the world's largest drug distribution networks. Its book value reflects the scale of its warehouses and logistics infrastructure that supplies medications to pharmacies and hospitals. The chart illustrates the importance of this critical link in the healthcare system.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Cencora Inc.
Cencora, one of the largest drug distributors, is valued by the market above the value of its massive warehouses. This premium reflects its indispensable role in the US healthcare system, its scale, and its efficiency, which allows it to deliver medications anywhere in the country. The chart illustrates this valuation.
Market to book capitalization ratio in a market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is a giant in the wholesale drug distribution industry. Its business relies on massive warehouses and complex logistics. This metric reflects how the market perceives its efficiency and indispensable role in the healthcare supply chain, awarding a premium to the value of its physical assets.
Market to book capitalization ratio for the market as a whole
Cencora (formerly AmerisourceBergen) is one of the three giants of wholesale pharmaceutical distribution in the US. It's a business with huge revenues but low margins, built on highly efficient logistics. This metric helps assess how the market values this critically important, yet low-margin, part of the healthcare system compared to other industries.
Debts of the company, segment and market as a whole
COR - Company debts Cencora Inc.
Cencora (formerly AmerisourceBergen), a global pharmaceutical distributor, operates with low margins but high turnover. Debt is used to finance working capital required to manage its massive drug inventory and for strategic acquisitions. This chart reflects a financial model optimized for its scale.
Market segment debts - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. Its business operates with low margins but huge turnover, requiring effective working capital management. This chart shows how the company uses financial instruments to support its extensive logistics network and fund strategic partnerships.
Market debt in general
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. The company's business model is based on high turnover and low margins, which requires effective working capital management. This chart allows you to evaluate how the company uses debt financing for its operations compared to the overall economic situation.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Cencora Inc.
Cencora (formerly AmerisourceBergen), one of the largest pharmaceutical distributors, operates with low margins but high turnover. This chart shows how the company uses debt to finance its working capital. It allows one to evaluate the effectiveness of its financial model and the risks associated with debt in the logistics business.
Market segment debt to market segment book capitalization - Pharmacy
Cencora (formerly AmerisourceBergen), a pharmaceutical distribution giant, is a key link in the healthcare supply chain. This chart shows its debt to total market capitalization for the entire sector. It helps understand how the company manages its working capital and finances its operations in a low-margin, high-volume business.
Debt to book value of all companies in the market
Cencora, a key pharmaceutical distributor, operates in the healthcare sector, which is considered defensive. This chart plots the company's debt against the overall market capitalization. It helps understand how stable this giant's financial policies are amid overall economic volatility, highlighting the non-cyclical nature of its business.
P/E of the company, segment and market as a whole
P/E - Cencora Inc.
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical wholesale distributors in the world. This chart shows how the market values its key role in the drug supply chain. The stable but moderate valuation reflects the business's low margins, yet its critical importance and huge sales volumes.
P/E of the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is a pharmaceutical distribution giant, a key link between drug manufacturers and pharmacies. This chart shows the average valuation for pharmaceutical distributors, helping to understand how the market values this critically important, yet low-margin, part of the healthcare system.
P/E of the market as a whole
Cencora (formerly AmerisourceBergen) is a key player in the drug supply chain, a wholesale distributor. This business is highly stable and has low margins. Does the company's valuation reflect its role as a "safe haven" in the healthcare sector, or is it susceptible to general market fluctuations, as illustrated by this indicator?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Cencora Inc.
Cencora (formerly AmerisourceBergen) is a key wholesale distributor of pharmaceutical products in the United States. The company's future profitability depends on drug sales volumes and the profitability of its logistics business. This chart shows analysts' expectations for the growth of the US healthcare market and the stability of its distribution model.
%20P%2FE%20Cencora%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Cencora-Inc.&v=1772646527695 "Chart of the company's future (projected) P/E Cencora Inc.")
Future (projected) P/E of the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is a pharmaceutical distribution giant, serving as a key link between drug manufacturers and pharmacies. This chart compares the company's future profitability expectations with those for the healthcare sector. It reflects the market's assessment of its role in the supply chain and the stability of its business model.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharmacy&v=1772646527702 "Future (projected) P/E graph of the market segment - Pharmacy")
Future (projected) P/E of the market as a whole
Cencora (formerly AmerisourceBergen) is a critical link in the pharmaceutical supply chain. This graph of overall market expectations helps assess the stability of their business. Regardless of the economic climate, demand for drugs remains high, providing Cencora with predictable cash flow.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772646527705 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Cencora Inc.
Cencora (formerly AmerisourceBergen) is a giant in the wholesale distribution of pharmaceuticals. This chart reflects its key role in the drug supply chain from manufacturers to pharmacies and hospitals. The company's profits, albeit low-margin, are generated by massive volumes and the efficiency of its logistics operations.
Profit of companies in the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world, serving as a link between drug manufacturers and pharmacies. This chart shows profitability in the pharmaceutical distribution sector. Cencora's scale and key role in the supply chain ensure its stable business, reflecting the overall health of the healthcare system.
Overall market profit
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the United States. The company is a key link between drug manufacturers and pharmacies. Its business is stable because demand for medications is constant. However, the overall economic situation, reflected in this chart, affects sales volumes and the financial health of its partners throughout the supply chain.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Cencora Inc.
Cencora, formerly AmerisourceBergen, is one of the largest pharmaceutical distributors in the world. This chart shows analysts' expectations for future revenue. The forecast is based on stable growth in demand for medications and the company's ability to effectively manage its complex supply chain, serving pharmacies and hospitals.
%20profit%20of%20the%20company%20Cencora%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Cencora-Inc.&v=1772646527752 "Graph of future (projected) profit of the company Cencora Inc.")
Future (predicted) profit of companies in the market segment - Pharmacy
Cencora, formerly AmerisourceBergen, is one of the three largest pharmaceutical distributors in the US, playing a key role in the drug supply chain. The profit forecasts for this sector, shown here, reflect trends in drug pricing and consumption volumes, providing insight into the stability of the business connecting pharmaceutical manufacturers and pharmacies.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharmacy&v=1772646527771 "Graph of future (predicted) profits of companies in a market segment - Pharmacy")
Future (predicted) profit of the market as a whole
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. The company is a key link between drug manufacturers and pharmacies/hospitals. Sales volumes are stable, but the overall economic growth, visible in the graph, is driving up healthcare spending and is favorable for Cencora.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772646527789 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Cencora Inc.
Cencora, formerly AmerisourceBergen, is a key link in the drug supply chain, delivering pharmaceuticals to pharmacies and hospitals. This chart shows how the market values the company's massive revenue. The low multiple is typical for distributors with low margins, but it underscores their systemic importance.
P/S market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world, serving as a key link between drug manufacturers and pharmacies. The company's revenue is enormous, but margins are low. This chart shows the average valuation in the sector, which helps understand how the market views Cencora's role in the healthcare supply chain.
P/S of the market as a whole
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. The company is a key link between drug manufacturers and pharmacies/hospitals. This chart helps understand how investors evaluate the revenue of a wholesale distributor with low margins but huge turnover, relative to the overall market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Cencora Inc.
Cencora (formerly AmerisourceBergen) is a giant pharmaceutical distributor that plays a central role in the healthcare supply chain. This chart shows how investors estimate the company's future earnings. Despite its low margins, the valuation is based on its huge and stable sales of life-saving medications.
%20P%2FS%20Cencora%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Cencora-Inc.&v=1772646527823 "The graph of the company's future (projected) P/S Cencora Inc.")
Future (projected) P/S of the market segment - Pharmacy
Cencora, formerly AmerisourceBergen, is one of the world's largest pharmaceutical distributors. This chart compares the company's estimated future revenue with other players in the pharmaceutical supply chain. It reflects the market's confidence in the stability of its logistics business and its ability to serve pharmacies and hospitals in a changing market.
%20P%2FS%20market%20segment%20graph%20-%20Pharmacy&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharmacy&v=1772646527829 "Future (projected) P/S market segment graph - Pharmacy")
Future (projected) P/S of the market as a whole
Cencora (formerly AmerisourceBergen) is one of the world's largest pharmaceutical distributors, serving as a link between drug manufacturers and pharmacies. Its business is characterized by high turnover and low profitability. This general outlook is less important to Cencora than demographic trends and drug consumption volumes, which are growing steadily.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772646527833 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Cencora Inc.
This chart shows the revenue of Cencora (formerly AmerisourceBergen), a pharmaceutical distribution giant. The company's revenue primarily comes from wholesale drug sales to pharmacy chains, hospitals, and clinics. The growth of this metric, albeit with low margins, demonstrates the vast size of the healthcare market and Cencora's key role in the drug supply chain.
Sales of companies in the market segment - Pharmacy
Cencora, formerly AmerisourceBergen, is one of the three largest pharmaceutical distributors in the United States. The company is a key link between drug manufacturers and pharmacies. This chart shows revenue trends in the pharmacy sector. It reflects overall drug spending in the country, the growth of which directly increases supply volumes and revenue for Cencora.
Overall market sales
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. It is a key link between drug manufacturers and pharmacies. Demand for medications is relatively stable, but overall economic growth, illustrated by this chart, ensures the financial stability of the healthcare system and the solvency of its clients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Cencora Inc.
Cencora, formerly AmerisourceBergen, is one of the largest pharmaceutical distributors in the world. The company's projected revenue chart reflects the expected growth of the global pharmaceutical market. Its stable growth is driven by forecasts of increased demand for medications, particularly for the high-cost, specialized drugs the company supplies.
%20sales%20of%20the%20company%20Cencora%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Cencora-Inc.&v=1772646527866 "Schedule of future (projected) sales of the company Cencora Inc.")
Future (projected) sales of companies in the market segment - Pharmacy
Cencora, formerly AmerisourceBergen, is a key player in the US drug supply chain. The company distributes pharmaceutical products from manufacturers to pharmacies and hospitals. This chart shows projected revenue for the entire pharmacy sector, reflecting drug sales expectations and overall healthcare trends.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharmacy&v=1772646527886 "Schedule of future (projected) sales of companies in the market segment - Pharmacy")
Future (projected) sales of the market as a whole
Cencora (formerly AmerisourceBergen) is a key link in the pharmaceutical supply chain. Market growth and overall healthcare spending, which often correlate with the overall economic situation, ensure a steady increase in the volume of pharmaceutical products passing through its distribution network.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772646527899 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Cencora Inc.
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors. This chart shows the efficiency of its logistics business, which operates with very low but stable margins. Profits are generated by huge sales volumes and exceptional operational efficiency in delivering medications to pharmacies and hospitals.
Market segment marginality - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the largest pharmaceutical distributors in the world. The company's business model is based on huge turnover and small but stable profit margins from supplying medications to pharmacies and hospitals. This chart shows the average profitability in the sector, allowing one to assess Cencora's operational efficiency on a large scale.
Market marginality as a whole
Cencora, formerly AmerisourceBergen, is one of the largest pharmaceutical distributors in the world. Its business is characterized by huge turnover and low but stable margins. Overall profitability, shown in the graph, has little impact on drug demand. For Cencora, demographic trends, patents on new drugs, and the efficiency of its own logistics are more important.
Employees in the company, segment and market as a whole
Number of employees in the company Cencora Inc.
Cencora (formerly AmerisourceBergen) is a quiet but vital player in the healthcare system. As one of the largest drug distributors, the company relies on its logistics army. This chart shows the scale of the team of warehouse workers and drivers who ensure timely delivery of medications to pharmacies and hospitals.
Share of the company's employees Cencora Inc. within the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is a vital, yet often invisible, link in the healthcare supply chain. The logistics of delivering medications from manufacturers to pharmacies and hospitals is a gigantic operation. This metric reveals its critical role, demonstrating the massive workforce it deploys to manage these vital flows of medications.
Number of employees in the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is a pharmaceutical distribution giant, the link between drug manufacturers and pharmacies. This chart illustrates the sheer scale of healthcare logistics. The consistently high employment rate demonstrates the importance and complexity of ensuring timely and safe delivery of medications across the country.
Number of employees in the market as a whole
Cencora is a vital link connecting drug manufacturers with pharmacies and hospitals. Its vast logistics staff ensures the smooth operation of the entire healthcare supply chain, which is a critical and significant part of the economy.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Cencora Inc. (COR)
Cencora (formerly AmerisourceBergen) is a pharmaceutical distribution giant. Their business is all about logistics and scale. This chart reflects their operating model. Huge volumes of drugs pass through their warehouses, but the business requires a significant staff. The chart shows the balance between how each employee's performance impacts margins in a low-margin business.
%20of%20the%20company%20Cencora%20Inc.%20(COR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Cencora-Inc.-COR&v=1772646527964 "Chart of market capitalization per employee (in thousands of dollars) of the company Cencora Inc. (COR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is a pharmaceutical distribution giant. It's a low-margin, high-volume business. The key to its success is logistics. This metric compares the market's valuation per employee to the industry average. It shows how effectively the market perceives a company to manage its warehouses and logistics compared to its competitors.
%20by%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharmacy&v=1772646527970 "Market capitalization per employee (in thousands of dollars) by market segment - Pharmacy")
Market capitalization per employee (in thousands of dollars) for the overall market
Cencora (formerly AmerisourceBergen) is a key link in the pharmaceutical supply chain. This metric reflects the essence of the logistics giant: huge volumes and turnover with relatively low margins. Value is created through scale and operational efficiency, and the chart shows how the market values this complex system, managed by a large staff.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772646527980 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Cencora Inc. (COR)
Cencora (formerly AmerisourceBergen) is one of the "big three" pharmaceutical wholesale distributors in the US. They serve as the link between drug manufacturers and pharmacies. This business is characterized by huge turnover but low margins. This chart shows how efficient their logistics are. Profit per employee depends on warehouse automation and scale.
%20Chart%20Cencora%20Inc.%20(COR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Cencora-Inc.-COR&v=1772646527986 "Company Profit Per Employee (in thousands of dollars) Chart Cencora Inc. (COR)")
Profit per employee (in thousands of dollars) in the market segment - Pharmacy
Cencora (AmerisourceBergen) is one of the "big three" drug distributors. This chart shows the benchmark for "Pharmaceuticals (Distribution)." The average profit per employee in this sector is extremely low. It's a logistics business with enormous turnover but microscopic margins (fractions of a percent). The benchmark reflects warehouse efficiency.
%20in%20the%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharmacy&v=1772646528006 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharmacy")
Profit per employee (in thousands of dollars) for the market as a whole
Cencora (formerly AmerisourceBergen) is a key link in the drug supply chain, connecting manufacturers and pharmacies. It's a business built on logistical efficiency and precision. This chart shows how profitable the pharmaceutical wholesale industry, which requires flawless organization, is per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772646528016 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Cencora Inc. (COR)
Cencora (formerly AmerisourceBergen) is a pharmaceutical distribution giant. This chart demonstrates the efficiency of their logistics model. Despite low margins, their enormous revenue per employee is achieved through the colossal volumes of drug deliveries to pharmacies and hospitals across the country.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Cencora-Inc.-COR&v=1772646528018 "Sales chart per company employee Cencora Inc. (COR)")
Sales per employee in the market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the "big three" wholesale drug distributors in the US. Their business is high-volume, low-margin logistics. Efficiency here is a matter of scale. This chart shows the industry average revenue per employee. It allows you to assess how efficient Cencora's logistics machine is compared to its competitors.
Sales per employee for the market as a whole
Cencora (formerly AmerisourceBergen) is one of the "big three" drug distributors in the US. Their business is logistics: they deliver drugs from manufacturers to pharmacies and hospitals. It's a business with huge turnover but very low margins. This chart shows the colossal amount of revenue that flows through each employee managing this complex supply chain.
Short shares by company, segment and market as a whole
Shares shorted by company Cencora Inc. (COR)
Cencora (formerly AmerisourceBergen) is one of the "big three" drug distributors in the US, supplying pharmacies and hospitals. This chart shows bearish sentiment. Skeptics may be concerned about margin pressure in distribution or ongoing legal risks related to the opioid crisis, which require billions in royalties.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Cencora-Inc.-COR&v=1772646528061 "Short Shares Chart for the Company Cencora Inc. (COR)")
Shares shorted by market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the "Big Three" wholesale drug distributors in the US. They are a key logistical link between pharmaceutical manufacturers and pharmacies. This chart shows bearish sentiment. Shorts on Cencora may reflect concerns about declining distribution margins due to regulatory pressure, as well as risks associated with lawsuits (for example, related to the opioid crisis).
Shares shorted by the overall market
Cencora (formerly AmerisourceBergen) is one of the "big three" wholesale drug distributors in the US. It's a stable but low-margin business. This indicator of overall market pessimism is less important for Cencora. However, fears of a recession could increase political pressure on drug prices, which indirectly impacts the entire healthcare supply chain.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Cencora Inc. (COR)
Cencora (formerly AmerisourceBergen) is one of the "big three" drug distributors in the US. It's a business with low margins but huge revenues. This oscillator shows the strength of a trend. COR shares rarely panic, but news of a major contract extension (for example, with Walgreens) or rising prices for brand-name drugs pushes the indicator higher.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Cencora-Inc.-COR&v=1772646528105 "RSI 14 indicator chart for the company's stock Cencora Inc. (COR)")
RSI 14 Market Segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the "big three" drug distributors in the US, a key link between pharmaceutical companies and pharmacies. The RSI_14_Seg for "Pharmacy" (pharmaceutical distribution) shows whether the sector is overbought. This helps separate Cencora's operating performance from the overall trend in the healthcare sector.
RSI 14 for the overall market
Cencora (COR) (formerly AmerisourceBergen) is one of the "big three" drug distributors in the US (along with MCK and CAH). They are the "logistics pipeline" for pharmaceuticals. This market "temperature" curve doesn't affect drug demand. Patients need them in both euphoria and panic. It's a "defensive" business with low margins but stable cash.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast COR (Cencora Inc.)
This chart shows the average Wall Street forecast for Cencora (AmerisourceBergen). The target price for this pharmaceutical distribution giant is a bet on rising healthcare costs. Analysts forecast the volume of "specialty" (high-priced) drugs it will handle. The consensus is a belief in the stability of the pharmaceutical distribution oligopoly.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-COR-Cencora-Inc.&v=1772646528119 "A chart showing analyst consensus forecasts for the expected stock price. COR (Cencora Inc.)")
The difference between the consensus estimate and the actual stock price COR (Cencora Inc.)
Cencora (COR), formerly AmerisourceBergen, is one of the big three wholesale drug distributors in the US, connecting pharmaceutical manufacturers and pharmacies. This chart shows their healthcare logistics assessment. It measures the gap between the price and the consensus target, reflecting the potential analysts see in their critical role in the drug supply chain.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-COR-Cencora-Inc.&v=1772646528130 "A chart showing the difference between the consensus forecast and the actual stock price. COR (Cencora Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the "big three" drug distributors in the US, supplying pharmacies and hospitals. This chart shows analysts' overall expectations for the drug distribution sector. It reflects whether experts see stability in healthcare supply chains or pricing pressure.
Analysts' consensus forecast for the overall market share price
Cencora (formerly AmerisourceBergen) is one of the big three drug distributors in the US. They are a critical logistical link, delivering medications from manufacturers to pharmacies and hospitals. General market sentiment, as shown in this chart, has little impact on their volumes (people are always getting sick), but it has a significant impact on the company's valuation and risks in the healthcare sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Cencora Inc.
Cencora (formerly AmerisourceBergen) is one of the big three wholesale drug distributors in the US. They are a critical link, delivering drugs from manufacturers to pharmacies and hospitals. This chart reflects their low-margin, high-turnover operating model. It measures the steady growth of the US pharmaceutical market, not drug prices.
AKIMA Market Segment Index - Pharmacy
Cencora (formerly AmerisourceBergen) is one of the big three drug distributors in the US, a vital link in the healthcare supply chain. This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how does Cencora's scale in pharmaceutical logistics and its partnership with Walgreens differentiate it from the average competitor?
The AKIM Index for the overall market
Cencora (formerly AmerisourceBergen) is one of the big three drug distributors in the US. It is a low-margin but critical logistics intermediary between pharmaceutical companies and pharmacies. This chart, reflecting the market average, provides context. It helps assess how this logistics giant, operating in the stable healthcare sector, compares to the overall macroeconomic fluctuations reflected by this indicator.
